Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021)

Historic Deferred Taxes for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Q4 2021 value amounting to $97000.0.

  • Insight Molecular Diagnostics' Deferred Taxes rose 16100.63% to $97000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$9.3 million, marking a year-over-year decrease of 63851.67%. This contributed to the annual value of -$9.3 million for FY2021, which is 63851.67% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Deferred Taxes stood at $97000.0 for Q4 2021, which was up 16100.63% from -$1.8 million recorded in Q2 2021.
  • In the past 5 years, Insight Molecular Diagnostics' Deferred Taxes ranged from a high of $97000.0 in Q4 2021 and a low of -$7.6 million during Q1 2021